Abiopharma

New SEC Form for ResMed Inc.

New SEC Form for ResMed Inc.

New SEC Form for ResMed Inc.

New SEC Form for ResMed Inc.

DEFA14A (Additional Proxy Soliciting Materials (definitive)) SEC Filing

Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere

NeuroSense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for PrimeC in ALS

Outlook Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

IFF推出智能配料机器人，革新香氛生产模式

IFFがスマート・ドージング・ロボットを導入、フレグランス生産の変革へ